[1]王淑平,李艳芳,孙 雪,等.茵陈蒿汤联合熊去氧胆酸治疗妊娠期肝内胆汁淤积症疗效及Th17/Treg失衡对妊娠结局的影响[J].陕西中医,2023,(8):1074-1077.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.017]
 WANG Shuping,LI Yanfang,SUN Xue,et al.Efficacy of Yinchenhao decoction combined with ursodeoxycholic acid in the treatment of ICP and the effect of Th17/Treg imbalance on pregnancy outcome[J].,2023,(8):1074-1077.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.017]
点击复制

茵陈蒿汤联合熊去氧胆酸治疗妊娠期肝内胆汁淤积症疗效及Th17/Treg失衡对妊娠结局的影响
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年8期
页码:
1074-1077
栏目:
临床研究
出版日期:
2023-08-05

文章信息/Info

Title:
Efficacy of Yinchenhao decoction combined with ursodeoxycholic acid in the treatment of ICP and the effect of Th17/Treg imbalance on pregnancy outcome
作者:
王淑平李艳芳孙 雪陈宝艳李道成刘志辉
(广州中医药大学第一附属医院,广东 广州 510405)
Author(s):
WANG ShupingLI YanfangSUN XueCHEN BaoyanLI DaochengLIU Zhihui
(First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Guangzhou 510405,China)
关键词:
妊娠期肝内胆汁淤积症 茵陈蒿汤 熊去氧胆酸 妊娠结局 辅助性T细胞17 调节性T细胞
Keywords:
Intrahepatic cholestasis of pregnancy Yinchenhao decoction Ursodeoxycholic acid Pregnancy outcome T helper cell 17 Treg
分类号:
R 575
DOI:
DOI:10.3969/j.issn.1000-7369.2023.08.017
文献标志码:
A
摘要:
目的:探究茵陈蒿汤联合熊去氧胆酸治疗妊娠期肝内胆汁淤积症(ICP)疗效及辅助性T细胞17(Th17)/调节性T细胞(Treg)失衡对妊娠结局的影响。方法:选择40例孕周>28周的ICP患者为研究对象,根据治疗方法分为西医组及联合组,西医组予熊去氧胆酸治疗,联合组予茵陈蒿汤联合熊去氧胆酸治疗,另选择孕周>28周正常健康孕妇为对照组。比较各组瘙痒评分、肝功能、白介素-17(IL-17)、白介素-35(IL-35)、转化生长因子-β(TGF-β)及妊娠结局的差异。采用Spearman秩相关性分析ICP患者IL-17、IL-35、TGF-β与妊娠结局的相关性。结果:联合组和西医组治疗前瘙痒评分、总胆汁酸(TBA)、直接胆红素(DBIL)、总胆红素(TBIL)、谷丙转氨酶(ALT)、谷草转氨酶(AST)、IL-17、IL-35及TGF-β水平比较差异无统计学意义(均P>0.05)。联合组和西医组患者治疗后瘙痒评分、TBA、DBIL、TBIL、ALT、AST、IL-17较治疗前下降,IL-35、TGF-β水平较治疗前升高(均P<0.05)。联合组治疗后瘙痒评分、TBA、DBIL、TBIL、ALT、AST、IL-17水平低于西医组,IL-35、TGF-β水平高于西医组(均P<0.05)。联合组早产、产后出血、低体重儿发生率低于西医组,Apgar评分高于西医组(均P<0.05)。联合组和对照组早产、产后出血、低体重儿发生率及Apgar评分比较差异无统计学意义(均P<0.05)。IL-17与早产、产后出血、低体重儿发生率及Apgar评分呈正相关(均P<0.05); IL-35、TGF-β与早产、产后出血、低体重儿发生率及Apgar评分呈负相关(均P<0.05)。结论:茵陈蒿汤联合熊去氧胆酸可显著改善ICP妊娠结局、肝功能、Th17/Treg失衡,且Th17/Treg失衡与妊娠结局密切相关。
Abstract:
Objective:To study the curative effect of Yinchenhao decoction combined with ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy(ICP)and the effect of Th17/Treg imbalance on pregnancy outcome.Methods:40 patients with ICP were selected as treatment objects,they were divided into western medicine group and combination group according to treatment methods.The western medicine group was treated with ursodeoxycholic acid,and the combination group was treated with Yinchenhao decoction combined with ursodeoxycholic acid.Healthy pregnant women with gestational age greater than 28 weeks were selected as the control group.The differences in pruritus score,liver function,IL-17,IL-35,TGF-β and pregnancy outcome were compared.Spearman rank correlation was used to analyze the correlation between IL-17,IL-35,TGF-β and pregnancy outcome in ICP patients.Results:There was no significant difference in the scores of pruritus,TBA,DBIL,TBIL,ALT,AST,IL-17,IL-35 and TGF-β between the combination group and the western medicine group before treatment(all P>0.05).After treatment,the pruritus scores,TBA,DBIL,TBIL,ALT,AST,IL-17 in the combination group and western medicine group were lower than those before treatment,and IL-35 and TGF-β were higher than those before treatment(all P<0.05).After treatment,the pruritus score,TBA,DBIL,TBIL,ALT,AST and IL-17 in the combined group were lower than those in the western medicine group,while IL-35 and TGF-β were higher than those in the western medicine group,and the difference was statistically significant(all P<0.05).The incidence of premature birth,postpartum hemorrhage and low birth weight infants in the combined group were lower than those of the western medicine group,and the Apgar score was higher than that of the western medicine group(all P<0.05).There was no significant difference between the combination group and the control group in terms of premature birth,postpartum hemorrhage,Apgar score and low birth weight infants(all P<0.05).IL-17 was positively correlated with premature birth,postpartum hemorrhage,Apgar score and low birth weight infants(all P<0.05); IL-35,TGF-β were negatively correlated with premature birth,postpartum hemorrhage,Apgar score and low birth weight infants(all P<0.05).Conclusion:Yinchenhao decoction combined with ursodeoxycholic acid can significantly improve ICP pregnancy outcome,liver function and Th17/Treg imbalance,and Th17/Treg imbalance is closely related to pregnancy outcome.

参考文献/References:

[1] Lin J,Gu W,Hou Y.Diagnosis and prognosis of early-onset intrahepatic cholestasis of pregnancy:A prospective study[J].J Matern Fetal Neonatal Med,2019,32(6):997-1003.
[2] 单 莉,周海燕,何菊仙,等.瘦素与妊娠期肝内胆汁淤积症的相关性研究[J].陕西医学杂志,2017,46(8):999-1001.
[3] 钱 静,闻 明.妊娠期肝内胆汁淤积症孕妇血清总胆汁酸水平与胎儿宫内窘迫关系及预测缺氧程度价值[J].中国计划生育学杂志,2022,30(10):2386-2388,2393.
[4] 张丽明,李素玉,王延安,等.胆瘀方结合熊去氧胆酸片及丁二磺酸腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症的临床分析[J].空军医学杂志,2018,34(1):65-68.
[5] 张 娟,樊延霞.妊娠期肝内胆汁淤积症患者胆固醇代谢相关基因表达及意义[J].陕西医学杂志,2021,50(5):575-578.
[6] 黄慧娟,谢青文.妊娠期肝内胆汁淤积症患者血清总胆汁酸和Th17/Treg平衡关系对围生儿结局的影响[J].中国妇幼保健,2022,37(20):3757-3760.
[7] 贺晶霞,安秀琴,刘近春.自噬相关信号分子在非酒精性脂肪性肝病中的作用[J].临床肝胆病杂志,2021,37(9):2220-2224.
[8] 王志梅,周晓娜,陈林兴.张良英教授辨证治疗妊娠期肝内胆汁淤积症经验介绍[J].云南中医中药杂志,2014,35(5):6-8.
[9] 胡荣魁,谈 勇.夏桂成国医大师调治妊娠诸疾经验探赜[J].江苏中医药,2015,47(12):1-4.
[10] 李京涛,焦俊喆,魏海梁,等.茵陈蒿汤对急性肝内胆汁淤积大鼠肠道黏膜屏障和NF-κB的影响[J].陕西中医,2019,40(5):547-549.
[11] 肖晓玲,刘晓燕.茵陈蒿汤加减治疗妊娠期肝内胆汁淤积症32例[J].中医临床研究,2021,13(4):113-115.
[12] 符慧慧.茵陈蒿汤治疗妊娠期肝内胆汁淤积症价值分析[J].实用中西医结合临床,2017,17(10):45-47.
[13] 曹书密.茵陈蒿汤联合西药治疗妊娠期肝内胆汁淤积综合征92例[J].深圳中西医结合杂志,2018,28(3):28-29.
[14] 楚艳贞.益心解毒汤联合磷酸肌酸钠治疗病毒性心肌炎疗效及对血清IL-6、IL-8、IL-35影响研究[J].陕西中医,2018,39(6):720-722.
[15] 孔 艳,孔 祥,张方圆.树突细胞及Th17/Treg在ICP患者的表达和临床意义[J].扬州大学学报:农业与生命科学版,2016,37(4):15-20.
[16] Ovadia C,Seed PT,Sklavounos A,et al.Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers:Results of aggregate and individual patient data meta-analyses[J].Lancet,2019,393(10174):899-909.
[17] Landgraf BJ,Mccarthy EL,Booker SJ.Radical s-adenosylmethionine enzymes in human health and disease[J].Annu Rev Biochem,2016,85:485-514.
[18] 何静怡,舒腾云,苏丽花,等.茵陈蒿的化学成分及其药理活性研究[J].云南中医药大学学报,2023,46(1):64-70.
[19] 王伊雯,郭 真,杜 曾,等.茵陈蒿汤和黄芪汤调控线粒体途径细胞凋亡防治胆汁淤积性肝损伤的比较研究[J].中华中医药杂志,2023,38(1):155-160.
[20] 袁颢宸,劳秋荣,王 宁.茵陈蒿汤的药理作用及临床应用[J].河南中医,2023,43(7):984-991.

相似文献/References:

[1]孙帅玲,马晓北.基于网络药理学探讨茵陈蒿汤治疗高脂血症作用机制[J].陕西中医,2021,(12):1793.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.038]
[2]李春晓,李怀臣.茵陈蒿汤调控Nrf-2/HO-1通路对慢性阻塞性肺疾病大鼠气道重塑的影响[J].陕西中医,2024,(8):1031.[doi:DOI:10.3969/j.issn.1000-7369.2024.08.005]
 LI Chunxiao,LI Huaichen.Effect of Yinchenhao decoction on airway remodeling in rats with chronic obstructive pulmonary disease by regulating the Nrf-2/HO-1 pathway[J].,2024,(8):1031.[doi:DOI:10.3969/j.issn.1000-7369.2024.08.005]

备注/Memo

备注/Memo:
基金项目:广东省科技计划项目(2017ZC0151)
更新日期/Last Update: 2023-08-10